Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Loomba

Showing results (401-410 of 636) with videos related to

Pageof 64
Sort By:
Hepatology (Baltimore, Md.)|September 27, 2019
Clinical Utility of an Increase in Magnetic Resonance Elastography in Predicting Fibrosis Progression in Nonalcoholic Fatty Liver DiseaseVeeral H Ajmera, Amy Liu, Seema Singh, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
N-acetyl-phenylalanine induces hepatic steatosis in MASLD by disrupting ER-mitochondria calcium coupling and mitochondrial lipid oxidationRémy Lefebvre, Théo Rousseaux, Nadia Bendridi, et al.
Journal of Hepatology|September 25, 2025
Genetic and non-genetic drivers of histological progression and regression in MASLDEduardo Vilar-Gomez, Katherine P Yates, David E Kleiner, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 25, 2023
Age, BMI, and Type 2 Diabetes Modify the Relationship Between PNPLA3 and Advanced Fibrosis in Children and Adults With NAFLDChaowapong Jarasvaraparn, Eduardo Vilar-Gomez, Katherine P Yates, et al.
Hepatology (Baltimore, Md.)|December 10, 2021
NASHFit: A randomized controlled trial of an exercise training program to reduce clotting risk in patients with NASHJonathan G Stine, Ian R Schreibman, Alison J Faust, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 11, 2025
Placebo Rates in Metabolic Dysfunction-Associated Steatohepatitis Clinical Trials: A Systematic Review and Meta-AnalysisFrancisco Idalsoaga, Luis Antonio Díaz, Saleh Alghsoon, et al.
European Radiology|November 21, 2023
A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography aloneSerkan Duman, Digdem Kuru, Mesut Gumussoy, et al.
Hepatology (Baltimore, Md.)|January 29, 2017
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysisParambir S Dulai, Siddharth Singh, Janki Patel, et al.
Therapeutic Advances in Gastroenterology|March 2, 2016
Cardiovascular risk assessment in the treatment of nonalcoholic steatohepatitis: a secondary analysis of the MOZART trialSteven C Lin, Brandon Ang, Carolyn Hernandez, et al.
Gastroenterology|December 14, 2020
Association of Genetic Variation With Cirrhosis: A Multi-Trait Genome-Wide Association and Gene-Environment Interaction StudyConnor A Emdin, Mary Haas, Veeral Ajmera, et al.
Pageof 64

Showing results (401-410 of 636) with videos related to

Sort By:
Pageof 64
Hepatology (Baltimore, Md.)|September 27, 2019
Clinical Utility of an Increase in Magnetic Resonance Elastography in Predicting Fibrosis Progression in Nonalcoholic Fatty Liver DiseaseVeeral H Ajmera, Amy Liu, Seema Singh, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
N-acetyl-phenylalanine induces hepatic steatosis in MASLD by disrupting ER-mitochondria calcium coupling and mitochondrial lipid oxidationRémy Lefebvre, Théo Rousseaux, Nadia Bendridi, et al.
Journal of Hepatology|September 25, 2025
Genetic and non-genetic drivers of histological progression and regression in MASLDEduardo Vilar-Gomez, Katherine P Yates, David E Kleiner, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 25, 2023
Age, BMI, and Type 2 Diabetes Modify the Relationship Between PNPLA3 and Advanced Fibrosis in Children and Adults With NAFLDChaowapong Jarasvaraparn, Eduardo Vilar-Gomez, Katherine P Yates, et al.
Hepatology (Baltimore, Md.)|December 10, 2021
NASHFit: A randomized controlled trial of an exercise training program to reduce clotting risk in patients with NASHJonathan G Stine, Ian R Schreibman, Alison J Faust, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 11, 2025
Placebo Rates in Metabolic Dysfunction-Associated Steatohepatitis Clinical Trials: A Systematic Review and Meta-AnalysisFrancisco Idalsoaga, Luis Antonio Díaz, Saleh Alghsoon, et al.
European Radiology|November 21, 2023
A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography aloneSerkan Duman, Digdem Kuru, Mesut Gumussoy, et al.
Hepatology (Baltimore, Md.)|January 29, 2017
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysisParambir S Dulai, Siddharth Singh, Janki Patel, et al.
Therapeutic Advances in Gastroenterology|March 2, 2016
Cardiovascular risk assessment in the treatment of nonalcoholic steatohepatitis: a secondary analysis of the MOZART trialSteven C Lin, Brandon Ang, Carolyn Hernandez, et al.
Gastroenterology|December 14, 2020
Association of Genetic Variation With Cirrhosis: A Multi-Trait Genome-Wide Association and Gene-Environment Interaction StudyConnor A Emdin, Mary Haas, Veeral Ajmera, et al.
Pageof 64